A. Unnisa, “Investigation of Terminalia arjuna as potential IL-4 and IL-13 modulator for the prevention of autoimmune diabetes: A Pharmacoinformatics-based study: DOI: 10.48129/kjs.17337”, KJS, vol. 50, no. 1A, Jan. 2023.